Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
98M
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
35.7M
-
Shares change
-
+1M
-
Total reported value, excl. options
-
$77M
-
Value change
-
+$2.32M
-
Put/Call ratio
-
2.01
-
Number of buys
-
30
-
Number of sells
-
-15
-
Price
-
$2.16
Significant Holders of aTYR PHARMA INC - COMMON STOCK (ATYR) as of Q2 2023
53 filings reported holding ATYR - aTYR PHARMA INC - COMMON STOCK as of Q2 2023.
aTYR PHARMA INC - COMMON STOCK (ATYR) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.7M shares
of 98M outstanding shares and own 36.4% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (10.2M shares), FMR LLC (8.14M shares), Stonepine Capital Management, LLC (4.63M shares), Tikvah Management LLC (2.46M shares), VANGUARD GROUP INC (2.3M shares), Alyeska Investment Group, L.P. (2.21M shares), BlackRock Inc. (1.37M shares), GEODE CAPITAL MANAGEMENT, LLC (593K shares), RENAISSANCE TECHNOLOGIES LLC (526K shares), and TWO SIGMA INVESTMENTS, LP (421K shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.